Technetium-99m-tetrofosmin uptake in sarcoidosis stage I

Journal of Nuclear Medicine

Volumn 38, Issue 11, 1997, Pages 1786-1787

  Tschabitscher, Doris ^a   Gallowitsch, Hans Jürgen ^a   Mikosch, Peter ^a   Kresnik, Ewald ^a   Gomez, Iris ^a   Molnar, Mario ^a   Dinges, H P ^a   Kroiss, Alois ^a   Lind, Peter ^a,b  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

Hilar lymphadenopathy; Sarcoidosis Stage I; SPECT; Technetium 99m tetrofosmin

Indexed keywords

TETROFOSMIN TC 99M;

AGED; ARTICLE; CANCER STAGING; CASE REPORT; DISEASE CLASSIFICATION; FEMALE; HEART PERFUSION; HUMAN; LYMPHADENOPATHY; MAMMOGRAPHY; MEDIASTINOSCOPY; PARATHYROID ADENOMA; PRIORITY JOURNAL; SARCOIDOSIS;

AGED; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPH NODES; MEDIASTINUM; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SARCOIDOSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030699316     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Alavi A, Palevsky HI. Gallium-67-citrate scanning in the assessment of disease activity in sarcoidosis. J Nucl Med 1992;33:751-755.
2. Heshiki A, Sanford L, Schatz SL, et al. Gallium-67-citrate scanning in patients with pulmonary sarcoidosis. Am J Röntgenol 1974;122:744-749.
3. Sulavik SB, Spencer RP, Weed DA, et al. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med 1990;31:1909-1914.
4. Masaoshi I, Hidemi N, Tsutomu K, et al. Tc-99m tetrofosmin. A new diagnostic tracer for parathyroid imaging. Clin Nucl Med 1995;10:902-905.
5. Gallowitsch HJ, Kresnik E, Mikosch et al. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma. Preliminary results. Nuclearmedizin 1996;35:230-235.
6. Lind P, Gallowitsch HJ, Langsteger W, et al. Technetium-99m tetrofosmin whole body scintigraphy in the follow up of differentiated thyroid carcinoma. J Nucl Med 1997;38:348-352.
7. Gallowitsch HJ, Kresnik E, Mikosch P, Lind P. Tc-99m sestamibi and Tc-99m tetrofosmin scintigraphy: alternative scintigraphic methods in follow up of DTC? First results. Eur J Nucl Med 1995;22:A909.
8. Lind P, Gallowitsch HJ, Kogler D, et al. Tc-99m tetrofosmin scintimammography: a prospective study in primary breast lesions. Nuclearmedizin 1996;35:225-229.
9. Rambaldi PF, Mansi L, Proccacini E, et al. Breast cancer detection with Tc-99m tetrofosmin. Clin. Nucl Med 1995;20:703-705.
10. Vieira MR, Weinholz JHB. Tc-99m tetrofosmin scintigraphy in the diagnosis of breast cancer. [Abstract] Eur J Nucl Med 1995;22:A742.
11. Diot P, Lemarie E, Baulieu JL, Pascal S, et al. Scintigraphy with J001 macrophage targeting glycolipopeptide. A new approach for sarcoidosis imaging. Chest 1992;102/ 3:670-676.
12. Schraml FV, Turton DB, Bakalar RS, Silverman ED. Persistent asymmetric pulmonary Tl-201 uptake in type III sarcoidosis. Clin Nucl Med 1995;20:1093-1094.
13. Actolun C, Bayhan H. Tc-99m MIBI uptake in pulmonary sarcoidosis. Preliminary results and comparison with Ga-67. Clin Nucl Med 1994;19:1063-1065.
14. Basoglu T, Sahin M, Coskunc C, et al. Technetium-99m-tetrofosmin uptake in malignant lung tumors. Eur J Nucl Med 1995;22:687-689.
15. Arbab AS, Koizumi K, Toyama K, Arki T. Uptake of technetium,99m tetrofosmin, technetium-99m MIBI and thallium 201 in tumor cell lines. J Nucl Med 1996;37: 1551-1556.